Genistein ameliorates hyperglycemia in a mouse model of nongenetic type 2 diabetes
Citations Over TimeTop 10% of 2012 papers
Abstract
While peripheral insulin resistance is common during obesity and aging in mice and people, the progression to type 2 diabetes (T2D) is largely due to loss of β-cell mass and function through apoptosis. We recently reported that genistein, a soy derived isoflavone, can improve glycemic control and β-cell function in insulin-deficient diabetic mice. However, whether it can prevent β-cell loss and diabetes in T2D mice is unknown. Our current study aimed to investigate the effect of dietary supplemented genistein in a nongenetic T2D mouse model. Nongenetic, middle-aged obese diabetic mice were generated by high fat diet and a low dose of streptozotocin injection. The effect of dietary supplementation of genistein on glycemic control and β-cell mass and function was determined. Dietary intake of genistein (250 mg·kg –1 diet) improved hyperglycemia, glucose tolerance, and blood insulin level in obese diabetic mice, whereas it did not affect body weight gain, food intake, fat deposit, plasma lipid profile, and peripheral insulin sensitivity. Genistein increased the number of insulin-positive β-cell in islets, promoted islet β-cell survival, and preserved islet mass. In conclusion, dietary intake of genistein could prevent T2D via a direct protective action on β-cells without alteration of periphery insulin sensitivity.
Related Papers
- → Biochemical Targets of the Isoflavone Genistein in Tumor Cell Lines(1995)166 cited
- → Signal Transduction Pathway Regulated by Genistein and its Therapeutic Use(2008)1 cited
- Synthesis of Genistein Sulfates and Effects of Genistein and its Sulfates on Proliferation of Breast Cancer Cells(2011)
- → Dietary genistein generates reduced blood pressure in female mice.(2006)
- 국제콩심포지움 ' 21 세기 인류건강을 위한 콩 ' ( International Soybean Symposium - Soya Power for Active and Healthy Life in the 21st Century ) : 유방암에 대한 제니스타인의 효과 - 화학적 예방요법 , 생체작용 기작과 생체 이용법 -(1998)